HCQ Fails to Prevent COVID-19 in Randomized Trial HCQ Fails to Prevent COVID-19 in Randomized Trial

Additionally, side effects were more common among participants in the HCQ group than the placebo group. One expert says the results raise the question of whether some ongoing trials should stop.Medscape Medical News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Infectious Diseases News Source Type: news